Trial Profile
A Phase 1 Open-label, Single-sequence Study to Evaluate the Effect of Concomitant Administration of BMS-986020 on the Single-dose Pharmacokinetics of Rosuvastatin in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jul 2014
Price :
$35
*
At a glance
- Drugs BMS 986020 (Primary) ; Rosuvastatin
- Indications Fibrosis; Idiopathic pulmonary fibrosis
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 12 Jun 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Apr 2014 New trial record